NCT05195879View on ClinicalTrials.gov

A Study of XTR004 Radiotracer in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions

Coronary Artery Disease (CAD)Myocardial Ischemia

Interventions

DIAGNOSTIC_TEST

XTR004

Single dose intravenous injection of XTR004. Serial whole-body PET scan will be obtain after injection, blood and urine collection after injection for the assessment of pharmacokinetics.

Trial Locations (1)

100000

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Sinotau Pharmaceutical Group

INDUSTRY

NCT05195879 - A Study of XTR004 Radiotracer in Healthy Volunteers | Biotech Hunter | Biotech Hunter